28.47USD-3.46%Mkt Cap: 2.45B USDP/E: —Last update: 2026-05-26
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid …
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
8.39BUSD—
7.49BSEKP/E 33.5
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
Indicators:|
Key Statistics
Company
Market Cap2.45B USD
Enterprise Value2.39B USD
Revenue (TTM)191.42M USD
Gross Profit135.20M USD
Net Income (TTM)-116.79M USD
Revenue/Share3.375 USD
Last Price28.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees843
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-110.46
PEG—
EV/EBITDA-35.51
EV/Revenue12.47
P/S13.16
P/B8.80
EPS (TTM)-3.09
EPS (Forward)-0.26
52W Range
20.1340% of range41.22
52W High41.22 USD
52W Low20.13 USD
Profitability
Gross Margin76.80%
Oper. Margin-41.88%
EBITDA Margin-35.10%
Profit Margin-66.35%
ROE-38.85%
ROA-32.49%
Growth
Revenue Growth41.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.02M USD
CapEx (TTM)5.03M USD
FCF Margin-25.42%
FCF Yield-1.98%
Net Debt-131.97M USD
Net Debt/EBITDA1.96
Balance Sheet
Debt/Equity0.07
Current Ratio5.57
Quick Ratio5.10
Book Value/Sh3.318 USD
Cash/Share1.836 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)37.00 USD
Target Range35.00 USD – 40.00 USD
# Analysts6
Ownership
Shares Out.86.24M
Float66.33M
Insiders5.16%
Institutions77.06%
Short Interest
Short Ratio3.6d
Short % Float7.34%
Short % Out.5.05%
Shares Short4.36M
Short (prev mo.)6.01M
Technical
SMA 5027.80 (+2.4%)
SMA 20030.07 (-5.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)1.12M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—